Company intelligence / Profile preview

Synovance

Evry, Île-de-France, Francesynovance.com ↗

Ownership: Private
Development stage: Commercial

Overview

Synovance has developed a proprietary synthetic genomics platform to engineer microbes that convert industrial waste into high-value chemicals, with its first commercial application being bio-produced indigo dye for the textile industry. The company has demonstrated successful scale-up at a 1000-liter pilot plant, increased production capacity tenfold, improved purity fourfold, and reduced costs fivefold over the past eight months. Paid proof-of-concept projects have been conducted with major denim brands and cosmetic companies.

Modalities: Microbial fermentationEngineered microorganisms (for chemical production)
Industry: Non-Drug Biotech

Partnerships

PureDenim (paid POC)World's largest jean brand (undisclosed)Three large cosmetic companies & one ingredient distributor for testing/validation

Beyond the preview

Go deeper on Synovance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synovance.

Explore the full profile